Navigation Links
Roche, Medivation, Santen and Biomarin Will Discuss CDISC Implementation Challenges at the Next Silicon Valley BioTalks
Date:9/12/2013

Sunnyvale, CA (PRWEB) September 12, 2013

The next session of the Silicon Valley BioTalks, a panel discussion and networking event sponsored by Clinovo, will take place on October 9th, 2013 at the CapGemini South San Francisco offices. The panel of experts from leading medical device and pharmaceutical companies will discuss the topic “CDISC for Medical Device Companies: Progress Made and Best Practices from Pharma/Biotech Implementation”. Free registration is open on clinovo.com/biotalks.

Now in its seventh session, this Silicon Valley BioTalks will host a panel of CDISC experts from leading pharmaceutical and medical device companies. The panel will discuss progress made regarding the implementation of CDISC standards in the past decade. It will be composed of CDISC thought-leaders: Carey Smoak (Roche Molecular Diagnostics, Senior Manager of SAS Programming, CDISC Device Team Leader), Debi Roy (Medivation, Head of Statistical Programming), Dan Diprimeo (BioMarin Pharmaceutical, Director of Statistical Programming) and Peng Yang (Santen Pharmaceutical, Associate Director, Head of Statistical Programming). The panel will be moderated by Ale Gicqueau (Clinovo, President & CEO). The Silicon Valley BioTalks will also include a networking session to facilitate discussions amongst attendees on the latest challenges around CDISC standards.

Pharmaceutical companies began adopting CDISC standards, such as SDTM (Study Data Tabulation Model), in 2004. By 2016, all data submitted to the FDA by pharmaceutical companies will need to meet CDISC standards. Although medical device companies may have until the next MDUFA (Medical Device User Fee Amendment) to comply with CDISC requirements, many companies are already implementing the medical device standards published in December 2012. ”At Clinovo, we are witnessing an acceleration in the adoption of CDISC standards”, states Ale Gicqueau, President & CEO at Clinovo. “We are looking forward to discussing the latest strategies favoring CDISC Implementation”.

Clinovo, a trusted CDISC® Registered Solutions Provider and Gold Member of the CDISC organization, is sponsoring the event. Clinovo has years of experience delivering SDTM conversion, training, and support services to pharmaceuticals and medical devices companies in the US and Europe. Clinovo developed CDISC Express, the first open source CDISC mapping tool. The recent 1.1 release of CDISC Express follows the new SDTM 3.1.3 specifications. The existing domains have been updated with more comprehensive variables and seven new medical device domains have been added from the new SDTM medical device guide.

Silicon Valley BioTalks is a premier event for pharmaceutical and medical device professionals to build their knowledge and expertise. Since its launch in June 2011, the Silicon Valley BioTalks gathered over 300 clinical trials professionals from the Bay Area and beyond. The panel has featured over 30 influential clinical trials industry experts, from leading life science companies including Roche, Abbott, Santen, Geron and Theravance. Read about the latest sessions on clinovo.com/biotalks.

About the CDISC organization

CDISC is a global, open, multidisciplinary, non-profit organization that has established standards to support the acquisition, exchange, submission, and archive of clinical research data and metadata. The CDISC mission is to develop and support global, platform-independent data standards that enable information system interoperability to improve medical research and related areas of healthcare. CDISC standards are vendor-neutral, platform-independent and freely available via the CDISC website.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11116066.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Effective treatment for late infantile batten disease developed by MU, BioMarin researchers
2. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
3. San Francisco’s Advanced Male Medical Center Announces Discount, Discusses Erectile Dysfunction
4. Dr. Carol Francis Radio Talk Show Discusses Sexual Abuse as Related to "Coach" Jerry Sandusky; Interview With Abuse Survivor Teresa Joyce, Author of "There's A Fine Line"
5. Columbus Allergist Dr. Summit Shah Discusses Recent Findings on Food Allergies and Exercise-Induced Anaphylaxis
6. Few Doctors Discuss Exercise With Cancer Patients: Study
7. Study demonstrates that earlier end of life care discussions are linked to less aggressive care in final days of life
8. Later End-of-Life Discussions May Mean More Aggressive Treatment
9. Internet Speaker, Founder, and President of RevenFlo Web Team, Jason Broadwater, Discusses the Most Essential Marketing Tool Available for Effective Internet Marketing
10. ‘A Subtle Addiction – Attacking the Y Generation’ the New Book by Peter and Lynn McIntosh Discusses Cell Phone Radiation - are Parents Nuking their Kids this Christmas?
11. Probiotic Action Responds to an Article Discussing the Health Benefits of Probiotics
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/29/2017)... (PRWEB) , ... April 29, 2017 , ... Phytomer USA ... As a Phytomer Account Manager, Smith’s role is to provide excellent customer ... that make up The Phytomer Group. Smith comes to Phytomer with a wealth of ...
(Date:4/28/2017)... ... April 28, 2017 , ... The National Campaign to ... the Access to Contraception for Women Servicemembers and Dependents Act of 2017. The ... will help to ensure that all members of the Armed Forces receive high ...
(Date:4/28/2017)... ... April 28, 2017 , ... Horizon Blue Cross Blue Shield of New Jersey ... “A” and its outlook as “stable.” At the same time, the ratings agency cautioned ... recent years, dip below “capital adequacy” thresholds required for its strong rating. , “Horizon ...
(Date:4/28/2017)... ... April 28, 2017 , ... The Radiology Business Management ... officers for 2017-2018. The annual board election process has been in place since the ... , Thomas C. Dickerson, Ed.D., FACHE, succeeds Jim Hamilton, MHA, CMM, FRBMA, as president. ...
(Date:4/28/2017)... ... April 28, 2017 , ... ... liability could substantially improve drug safety and minimize the cost of development. In ... ion channel inhibition using cell lines and for cardiac toxicity using induced pluripotent ...
Breaking Medicine News(10 mins):
(Date:4/19/2017)... 19, 2017  Novartis today announced the publication ... Lung, and Blood Institute (NHLBI) of the National ... patients with treatment-naïve severe aplastic anemia (SAA) achieved ... eltrombopag at the initiation of and concurrently with ... three sequential treatment groups, or cohorts. Cohort 3 ...
(Date:4/18/2017)... MINNEAPOLIS , April 18, 2017 Cogentix ... focused on providing the Urology, Uro/Gyn and Gynecology markets ... for the first quarter ended March 31, 2017 after ... The Company will host a conference call ... day on Tuesday, May 2, 2017 at 4:30 p.m. ...
(Date:4/18/2017)... , April 18, 2017  Astute Medical, Inc., developer ... series to be presented at the 2017 National Kidney ... today and continues through April 22. Physicians will present ... used to assess risk for acute kidney injury (AKI) ... failure (ADHF). Elevated levels of TIMP-2 ...
Breaking Medicine Technology: